Your browser doesn't support javascript.
loading
Comparison of different 2D and 3D-QSAR methods on activity prediction of histamine H3 receptor antagonists
IJPR-Iranian Journal of Pharmaceutical Research. 2012; 11 (1): 97-108
en Inglés | IMEMR | ID: emr-131715
ABSTRACT
Histamine H3 receptor subtype has been the target of several recent drug development programs. Quantitative structure-activity relationship [QSAR] methods are used to predict the pharmaceutically relevant properties of drug candidates whenever it is applicable. The aim of this study was to compare the predictive powers of three different QSAR techniques, namely, multiple linear regression [MLR], artificial neural network [ANN], and HASL as a 3D QSAR method, in predicting the receptor binding affinities of arylbenzofuran histamine H3 receptor antagonists. Genetic algorithm coupled partial least square as well as stepwise multiple regression methods were used to select a number of calculated molecular descriptors to be used in MLR and ANN-based QSAR studies. Using the leave-group-out cross-validation technique, the performances of the MLR and ANN methods were evaluated. The calculated values for the mean absolute percentage error [MAPE], ranging from 2.9 to 3.6, and standard deviation of error of prediction [SDEP], ranging from 0.31 to 0.36, for both MLR and ANN methods were statistically comparable, indicating that both methods perform equally well in predicting the binding affinities of the studied compounds toward the H3 receptors. On the other hand, the results from 3D-QSAR studies using HASL method were not as good as those obtained by 2D methods. It can be concluded that simple traditional approaches such as MLR method can be as reliable as those of more advanced and sophisticated methods like ANN and 3D-QSAR analyses
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Iran. J. Pharm. Res. Año: 2012

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Iran. J. Pharm. Res. Año: 2012